Steroid maker sold other drugs in MN
A Massachusetts company at the center of a deadly meningitis outbreak was selling medications to some of the largest medical groups in Minnesota even though it had no license to do so, the Star Tribune has learned. The New England Compounding Center, which is under investigation for selling tainted steroids, has supplied a host of other drugs to the Mayo Clinic, Allina, HealthPartners and other hospitals and clinics—many more than previously disclosed—officials confirmed in interviews. Questions are surfacing about the company's sales practices as it went around the country marketing hundreds of drugs to hospitals and clinics even though it was not subject to the strict federal safety rules that apply to drug manufacturers.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- Large Employers Trimming Healthcare Spending
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital